Scienture Holdings Holds Exclusive U.S. Distribution Rights For Kindeva Drug Subsidiary Summit BioSciences' Rezenopy Nasal Spray, Which Received A U.S. Patent Effective May 12

뉴스 본문을 불러오고 있어요.

Scienture Holdings Holds Exclusive U.S. Distribution Rights For Kindeva Drug Subsidiary Summit BioSciences' Rezenopy Nasal Spray, Which Received A U.S. Patent Effective May 12 | 웨이프 WAPE

Scienture Holdings Holds Exclusive U.S. Distribution Rights For Kindeva Drug Subsidiary Summit BioSciences' Rezenopy Nasal Spray, Which Received A U.S. Patent Effective May 12

기사 요약

관련 종목

댓글 —